JP2025502208A5 - - Google Patents
Info
- Publication number
- JP2025502208A5 JP2025502208A5 JP2024541809A JP2024541809A JP2025502208A5 JP 2025502208 A5 JP2025502208 A5 JP 2025502208A5 JP 2024541809 A JP2024541809 A JP 2024541809A JP 2024541809 A JP2024541809 A JP 2024541809A JP 2025502208 A5 JP2025502208 A5 JP 2025502208A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263299599P | 2022-01-14 | 2022-01-14 | |
| US63/299,599 | 2022-01-14 | ||
| US202263384704P | 2022-11-22 | 2022-11-22 | |
| US63/384,704 | 2022-11-22 | ||
| PCT/EP2023/050702 WO2023135237A1 (en) | 2022-01-14 | 2023-01-13 | Tryptamine compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025502208A JP2025502208A (ja) | 2025-01-24 |
| JPWO2023135237A5 JPWO2023135237A5 (https=) | 2026-01-20 |
| JP2025502208A5 true JP2025502208A5 (https=) | 2026-01-20 |
Family
ID=85018123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541809A Pending JP2025502208A (ja) | 2022-01-14 | 2023-01-13 | トリプタミン組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250051279A1 (https=) |
| EP (1) | EP4463440A1 (https=) |
| JP (1) | JP2025502208A (https=) |
| KR (1) | KR20240134951A (https=) |
| AU (1) | AU2023207801B2 (https=) |
| CA (1) | CA3259235A1 (https=) |
| IL (1) | IL313889A (https=) |
| MX (1) | MX2024008691A (https=) |
| WO (1) | WO2023135237A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4618981A1 (en) | 2022-11-17 | 2025-09-24 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| WO2026013174A1 (en) | 2024-07-10 | 2026-01-15 | Cybin Uk Ltd | Pharmaceutical compositions comprising deuterated n,n-dimethyltryptamine |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| ID28302A (id) | 1999-01-14 | 2001-05-10 | Teijin Ltd | Alat untuk mengumpankan suatu bubuk dalam jumlah tertentu |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| NZ514442A (en) | 1999-03-03 | 2003-08-29 | Optinose As | Nasal delivery device |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| GB0019715D0 (en) | 2000-08-10 | 2000-09-27 | Pa Consulting Services | Device for delivering physiologically active agent in powdered form |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| JP4795637B2 (ja) | 2001-09-28 | 2011-10-19 | カーブ テクノロジー，インコーポレイティド | 鼻ネブライザー |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| WO2021234608A1 (en) * | 2020-05-19 | 2021-11-25 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| KR20240096817A (ko) * | 2020-05-19 | 2024-06-26 | 사이빈 아이알엘 리미티드 | 중수소화된 트립타민 유도체 및 사용 방법 |
| US12042564B2 (en) * | 2020-06-02 | 2024-07-23 | Cybin Uk Ltd | Therapeutic solid dosage forms |
| EP3902541B1 (en) * | 2020-06-02 | 2022-09-14 | Small Pharma Ltd | Therapeutic compositions comprising deuterated or partially deuterated n,n-dimethyltryptamine compounds |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
| JP2023544724A (ja) * | 2020-10-02 | 2023-10-25 | サイビン アイアールエル リミテッド | 吸入による幻覚発動薬の送達方法および方法を実施するためのシステム |
| IL303288A (en) * | 2020-12-01 | 2023-07-01 | Small Pharma Ltd | N,N-Dimethyltryptamine compounds partially or fully deuterated |
-
2023
- 2023-01-13 US US18/720,922 patent/US20250051279A1/en active Pending
- 2023-01-13 WO PCT/EP2023/050702 patent/WO2023135237A1/en not_active Ceased
- 2023-01-13 AU AU2023207801A patent/AU2023207801B2/en active Active
- 2023-01-13 CA CA3259235A patent/CA3259235A1/en active Pending
- 2023-01-13 JP JP2024541809A patent/JP2025502208A/ja active Pending
- 2023-01-13 MX MX2024008691A patent/MX2024008691A/es unknown
- 2023-01-13 IL IL313889A patent/IL313889A/en unknown
- 2023-01-13 EP EP23700949.3A patent/EP4463440A1/en active Pending
- 2023-01-13 KR KR1020247026687A patent/KR20240134951A/ko active Pending